Task: Translation
Input (Czech): Farmaceutické prostredky obsahující kyselinu zolendronovou, její farmaceuticky prijatelnou sul nebo libovolný jejich hydrát, tj. bisfosfonát, pro lécení stavu s abnormálne zvýšeným kostním obratem, napr. osteoporózy, které se podávají prerušovane a období mezi jejich podáními ciní alespon 6 mesícu.
Output (English): In the present invention, there are disclosed pharmaceutical compositions containing zoledronic acid a pharmaceutically acceptable salt thereof or an arbitrary hydrate thereof, i.e. bisphosphonate for treating conditions of abnormally increased bone turnover, such as osteoporosis, by intermittent administration, wherein the periods between bisphosphonate administrations are longer than was previously considered appropriate, e.g. a dosing interval of at least about 6 months or less frequently.